1-(4-Bromothiazol-2-yl)piperidin-4-ol, 95.0%, 5g

3-Guanidinopropanoic acid, 95.00%, 10g

3,4,5-Trifluorophenylacetic acid, 97.0%, 25g

4-aminophénol, min.98%, pour la synthèse, 500 g, emballage en verre

TRIPROPARGYLAMINE, 97.0%, 1g

3-(5-(Methoxycarbonyl)-1H-pyrrol-2-yl)propanoic acid, 97%, 5g

5-Ethynyl-1H-pyrazole, 95+%, 1g

3,5-Dibromophenylboronic acid, 97.0%, 1g

(1S,3R)-3-Hydroxycyclohexane-1-carboxylic acid, 98%, 500mg

Ethyl 5-(3-Chloro-5-fluorophenyl)-5-oxovalerate, 97.0%, 1g

Tert-butyl 4-(4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 95%, 5g

Ethyl 2-(adamantan-1-ylamino)-2-oxoacetate, 98%, 5g

N,N'-Diisopropylcarbodiimide>98.0%(GC)250g